Home/GlycoTherapeutics/Dr. Leendert van den Bos
DL

Dr. Leendert van den Bos

Head of Business Development

GlycoTherapeutics

Roles

Head of Business DevelopmentatGlycoTherapeutics
CEOatEnzyTag

GlycoTherapeutics Pipeline

DrugIndicationPhase
Undisclosed Glycan-Disruption ProgramOncology (Immunotherapy combination)Pre-clinical